Politicians are contemplating raising taxes and cutting benefits as the cost of health care for government workers surges.

In a Phase 3 trial of people with post-bariatric hypoglycemia, those taking the drug, avexitide, experienced a 55% reduction in the rate of serious low blood sugar events compared with placebo.

Over a dozen states now have laws enhancing their oversight of private equity deals in health care. A new report says that’s ...

Every August, Epic Systems founder Judy Faulkner holds court with over 20,000 people, including staff and executives from her most devoted customers, in an auditorium buried five stories into the ...

UnitedHealth faces an investigation over tax payments, and we examine why PE deals for doctor groups are slowing.

AstraZeneca is discontinuing a late-stage drug trial in patients with metastatic non-small cell lung cancer, extending a run ...

The Internal Revenue Service is investigating UnitedHealth Group, with an initial probe determining the health care ...

The change in tone — from day to day and coast to coast — shows how Kennedy’s sprawling political messages tied to his Make ...

Europe pulls Tavneos over trial integrity concerns, pricing concerns over AstraZeneca's hypertension drug, and more biotech ...

An executive order remaking the federal vaccine agenda, Epic's antitrust lawsuits, and more health news from Morning Rounds ...

Sanofi, one of the Massachusetts' largest pharmaceutical employers, will lay off more than 200 workers there a year after acquiring Blueprint Medicines.

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. A flurry of scientific gatherings and panels across federal science ...